Your family's health, including yours, is our treasure of wealth.
Singapore ranks fourth in the world in terms of basic healthcare facilities, seventh in terms of life expectancy, as well as first in Asia and sixth globally in terms of healthcare system.
At present, there are a total of 13 medical institutions in Singapore that have been accredited by the Joint Commission International (JCI), in which the numbers constitute to one third of the total numbers in Asia region.
As a leading healthcare hub in Asia, Singapore's healthcare system has a total of eight major advantages.
Advanced healthcare system
Singapore's state-of-the-art healthcare system offers first-class medical services and remarkable treatment effectiveness, Singapore's healthcare system has an advanced level.
Competitive pricing
Compared with Europe and the United States, Singapore’s medical costs are very competitive, and the total cost of various treatments may only be 1/3 to 1/2 of that in Europe and the United States.
Convenient and seamless communication
Singapore’s bilingual environment allows most doctors to communicate in Mandarin or English directly with patients.
Quality service and environment
Singapore's medical and healthcare institutions implement the concept of "patient-orientated" and improve patient's environment continuously to provide medical services in an effective manner.
World-class research level
Singapore is a renowned research and clinical trial centre. It is also an Asia biomedical research centre that is equipped with advanced R&D facilities for medical developments.
Convenient and fast transportation
Most China's inland and coastal provinces have approved direct flights to Singapore, with majority of them only last around 3-6 hours.
Strict privacy regulations
Singapore’s hospitals have strict regulations on prevention of disclosing private information and breaching of patients' privacy by imposing severe penalties.
On-time update of new drugs
Singapore's clinical trials have extensive years of experience and great reputation, and they are primarily the first choice for major pharmaceutical companies to perform clinical trials of new drugs.
Copyright © Eureka Investment Group (Singapore) Private Limited.
All Rights Reserved | Privacy Consent